- Recent advances in uncovering the mechanisms contributing to BIRD-2-induced cell death in B-cell cancer cells(2019)
Auteurs: Martijn Kerkhofs, Tamara Vervloessem, Geert Bultynck
- Exploring and exploiting Bcl-2'S anti-apoptotic function in diffuse large B-cell lymphoma: BH4 domain versus the hydrophobic cleft(2018)
Auteurs: Tamara Vervloessem, Geert Bultynck
Aantal pagina's: 128
- Bcl-2 inhibitors as anti-cancer therapeutics: the impact of and on calcium signaling(2018)
Auteurs: Tamara Vervloessem, Martijn Kerkhofs, Rita La Rovere, Flore Sneyers, Jan Parys, Geert Bultynck
Pagina's: 102 - 116
- Reciprocal sensitivity of diffuse large B-cell lymphoma cells to Bcl-2 inhibitors BIRD-2 versus venetoclax(2017)
Auteurs: Tamara Vervloessem, Haidar Akl, Thomas Tousseyn, Humbert De Smedt, Jan Parys, Geert Bultynck
Pagina's: 111656 - 111671
- The selective Bcl-2 inhibitor venetoclax, a BH3 mimetic, does not dysregulate intracellular Ca2+ signaling(2017)
Auteurs: Tamara Vervloessem, Hristina Ivanova, Jan Parys, Geert Bultynck
Pagina's: 968 - 976
- Antagonizing Bcl-2's BH4 domain in cancer(2015)
Auteurs: Tamara Vervloessem, Rita La Rovere, Geert Bultynck
Pagina's: 748 - 9
- The type 2 inositol 1,4,5-trisphosphate receptor, emerging functions for an intriguing Ca2+-release channel(2015)
Auteurs: Tamara Vervloessem, Geert Bultynck, Jan Parys
Pagina's: 1992 - 2005
- A dual role for the anti-apoptotic Bcl-2 protein in cancer: Mitochondria versus endoplasmic reticulum(2014)
Auteurs: Haidar Akl, Tamara Vervloessem, Santeri Kiviluoto, Mart Bittremieux, Jan Parys, Humbert De Smedt, Geert Bultynck
Pagina's: 2240 - 2252